Trial Profile
Active GLP-1 as prediction Factor of Effect of Sitagliptin on patients with Type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jul 2016
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms A GLP-1 FEST
- 06 Jul 2016 Status changed from active, no longer recruiting to completed.
- 09 May 2013 New trial record